Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2Prostatic Neoplasms 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Oligodendroglioma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Meningioma 1Kidney Neoplasms 1Inflammatory Breast Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Esthesioneuroblastoma, Olfactory 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Breast Neoplasms, Male 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1Adenocarcinoma, Follicular 1

Interventions

Iodine-131 5lenvatinib 3X-Rays 3Thyrotropin Alfa 3Magnetic Resonance Spectroscopy 3trametinib 2dabrafenib 2Sunitinib 2Specimen Handling 2Interviews as Topic 2vandetanib 1tremelimumab 1spartalizumab 1selpercatinib 1pembrolizumab 1pazopanib 1durvalumab 1cobimetinib 1cabozantinib 1Vemurafenib 1Thyrotropin 1Thalidomide 1Surgical Procedures, Operative 1Sorafenib 1Sodium Iodide 1Semaxinib 1Photons 1Photochemotherapy 1Phantoms, Imaging 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma, Follicular × Semaxinib × Clear all
NCT00005647 2010-06-10

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Case Comprehensive Cancer Center

Phase 1 Completed
12 enrolled
CNSEndocrineHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡